3 Common Psychiatric Disorders in Older Adults: New Insights

September 5, 2017

Slideshow

Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?

View the slides in PDF format.

Related Videos

Related Content

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

The Week in Review: July 17-21

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Experimental Drug Slows Progression of Alzheimer Disease in Patients With Mild Impairment by 60%

The Week in Review: July 3-7

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

The Week in Review: July 17-21

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Experimental Drug Slows Progression of Alzheimer Disease in Patients With Mild Impairment by 60%

The Week in Review: July 3-7

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

The Week in Review: July 17-21

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Experimental Drug Slows Progression of Alzheimer Disease in Patients With Mild Impairment by 60%

The Week in Review: July 3-7

Related Content

What is new in research on sleep?

Sleep Research Roundup: September 29

September 29th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

What Will the Future of Alzheimer Disease Treatment Look Like?

From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.

The Week in Review: July 17-21

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Trial results underscore the importance of early diagnosis and treatment in patients with Alzheimer disease.

Experimental Drug Slows Progression of Alzheimer Disease in Patients With Mild Impairment by 60%

From the FDA traditional approval of Leqembi to an examination of how we can improve mental health care for women of color, here are highlights from the week in Psychiatric Times.

The Week in Review: July 3-7

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.